Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06587022
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-04
Brief Title:
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ST-SBRT
Brief Summary:
The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors
Detailed Description:
The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors This is a bidirectional cohort study planned to enroll approximately 500 patients with metastatic spinal tumors Patients are divided into two groups according to the target delineation method Group 1The target bolume only includes local tumor Group 2The target bolume includes local tumor and adjacent vertebral area
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None